| Size | Price | Stock | Qty |
|---|---|---|---|
| 5g |
|
||
| 10g |
|
||
| Other Sizes |
Purity: N/A
| Targets |
Not applicable (chromatography media). Sephadex G-200 does not have a pharmacological target as it is not a drug but a chromatography medium. It functions as a size-exclusion matrix for the separation of molecules based on their molecular size. The compound does not interact with biological targets in a pharmacological sense.
|
|---|---|
| ln Vitro |
Not applicable.
|
| ln Vivo |
Not applicable.
|
| Enzyme Assay |
Sephadex G-200 is used in size-exclusion chromatography (SEC) for the separation of biomolecules. The gel is hydrated in an appropriate buffer and packed into a chromatography column. Samples are applied to the column, and molecules are eluted with the same buffer. Larger molecules elute first because they are excluded from the pores, while smaller molecules enter the pores and elute later. The separation range for Sephadex G-200 is approximately 5,000 to 800,000 Da for globular proteins. Standard protocols for gel preparation, column packing, and chromatography are available from the manufacturer.
|
| Cell Assay |
Not applicable.
|
| Animal Protocol |
Not applicable.
|
| ADME/Pharmacokinetics |
Not applicable.
|
| Toxicity/Toxicokinetics |
Sephadex G-200 is a beaded, cross-linked dextran gel. It is available in various particle sizes (e.g., superfine, fine, medium, coarse). The gel should be stored in a wet state with a preservative (e.g., 0.02% sodium azide) to prevent microbial growth. It should be stored at 4-30°C and protected from drying. The gel has a typical exclusion limit of approximately 5,000-800,000 Da for globular proteins.
|
| References |
[1]. Ogston AG, et al. The thermodynamics of interaction between Sephadex and penetrating solutes. Biochem J. 1970 Jan;116(2):171-5.
|
| Additional Infomation |
See also: Osmanthus Oil (Note moved to).
Sephadex G-200 is a chromatography medium and is not intended for human or animal use. It is generally considered non-toxic. However, standard laboratory safety practices should be followed when handling the gel and the buffers used with it. The preservative (e.g., sodium azide) is toxic and should be handled with care. |
| Exact Mass |
2251.65
|
|---|---|
| CAS # |
9041-36-5
|
| Related CAS # |
Sephadex G 50;9048-71-9;Sephadex G 100;9050-94-6;Sephadex G 15;11081-40-6;Sephadex G 10;9050-68-4;Sephadex G 150;12774-36-6
|
| PubChem CID |
168010037
|
| Appearance |
White to off-white solid powder
|
| Hydrogen Bond Donor Count |
5
|
| Hydrogen Bond Acceptor Count |
36
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
163
|
| Complexity |
2630
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1CC2=C(C=CC=C2F)C(N3CN(CC=C1)C(=O)C4=C(C(=O)C=CN43)O)C5=NC(=CC=C5)F.C1C=CCOC2=C(C=CC=C2Cl)C(N3CN1C(=O)C4=C(C(=O)C=CN43)O)C5=CC=CC=C5.C1C=CCOC2=C(C=CC=C2Cl)C(N3CN1C(=O)C4=C(C(=O)C=CN43)O)C5=CC=CC=C5.C1C=CCOC2=C(C=CC(=C2F)F)C(N3CN1C(=O)C4=C(C(=O)C=CN43)O)C5=CC=CC=C5.C1C=CCOC2=C(C=CC(=C2F)F)C(N3CN1C(=O)C4=C(C(=O)C=CN43)O)C5=CC=CC=C5
|
| InChi Key |
XDTNUBTXHWPZST-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/2C24H20ClN3O4.C24H20F2N4O3.2C24H19F2N3O4/c2*25-18-10-6-9-17-20(16-7-2-1-3-8-16)28-15-26(12-4-5-14-32-23(17)18)24(31)21-22(30)19(29)11-13-27(21)28;25-17-8-4-7-16-15(17)6-2-1-3-12-28-14-30(21(16)18-9-5-10-20(26)27-18)29-13-11-19(31)23(32)22(29)24(28)33;2*25-17-9-8-16-20(15-6-2-1-3-7-15)29-14-27(11-4-5-13-33-23(16)19(17)26)24(32)21-22(31)18(30)10-12-28(21)29/h2*1-11,13,20,30H,12,14-15H2;1,3-5,7-11,13,21,32H,2,6,12,14H2;2*1-10,12,20,31H,11,13-14H2
|
| Chemical Name |
7-chloro-17-hydroxy-2-phenyl-9-oxa-1,14,21-triazatetracyclo[12.7.1.03,8.016,21]docosa-3(8),4,6,11,16,19-hexaene-15,18-dione;6,7-difluoro-17-hydroxy-2-phenyl-9-oxa-1,14,21-triazatetracyclo[12.7.1.03,8.016,21]docosa-3(8),4,6,11,16,19-hexaene-15,18-dione;7-fluoro-2-(6-fluoropyridin-2-yl)-17-hydroxy-1,14,21-triazatetracyclo[12.7.1.03,8.016,21]docosa-3(8),4,6,11,16,19-hexaene-15,18-dione
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solubility (In Vivo) |
Dextran Gel G Series Instructions for Use 1. Chemical and Physical Properties Dextran Gel is a beaded gel containing a large number of hydroxyl groups, allowing it to swell readily in water and electrolyte solutions. The hydrophilic matrix minimizes non-specific adsorption and provides high recovery rates during biomolecule separation. G-type Dextran Gels have varying degrees of cross-linking, resulting in different swelling degrees and fractionation ranges. The swelling degree of Dextran Gel is essentially unaffected by the presence of salts or detergents. 2. Product Specifications
3. Usage Instructions Sephadex series products are supplied as dry powders and must be swollen before use. Avoid excessive stirring during swelling as it may damage the packing material. Do not use magnetic stirrers. 3.1 Packing Material Preparation (1) Swell the packing material in an excess of deionized water or buffer at room temperature for 24 hours, or in hot water for 1 hour (Not in a water bath!). The elution buffer should not contain high-viscosity reagents. If floating matter appears on the upper layer during swelling, remove it. (2) Equilibrate the swollen packing material and all buffers to the experimental operating temperature. Degas all buffers. 3.2 Column Packing (1) Inspect all column components, especially the filter screen, sealing ring, and screw plug for tightness. Ensure the glass tube is clean and intact. (2) Wet the column interior and bottom end with water or buffer, maintaining a small liquid level. Ensure no air bubbles are present at the bottom. (3) Use a glass rod to guide the slurry into the column along the inner wall in one continuous pour, avoiding bubble formation. Open the column outlet to allow the gel to settle freely within the column. Connect the top column end fitting securely. (4) Start the peristaltic pump and allow buffer to flow through the column at 1.33 times the operating flow rate to stabilize the bed (Ensure pressure does not exceed the maximum pressure resistance of the packing material). 3.3 Equilibration Equilibrate the column with at least 5-10 column volumes (CV) of buffer before sample application until the recorder baseline stabilizes (i.e., the pH and conductivity of the effluent equal those of the application buffer). 3.4 Sample Application Samples must be centrifuged or filtered (0.45 µm filter) before application. For gel filtration, the sample volume is generally no more than 5% of the bed volume. For initial runs, it is recommended to load 1-2% of the bed volume and adjust based on separation results. For desalting, sample volumes up to 20% of the bed volume can be applied. Column height also affects separation; taller columns provide better resolution but cause higher backpressure and should be avoided if possible. Challenging separations require adequate column height and flow rate control. For desalting, a height-to-diameter ratio of 5:1 is sufficient. 3.5 Elution Method Elution can be performed using salt-free water or the buffer used during column packing. 3.8 Cleaning In Place (CIP) Perform CIP after every ten uses to remove precipitated and stubbornly adsorbed proteins. Method: Wash with 0.1 M NaOH for 2 column volumes (CV), followed by regeneration with at least 10 CV of equilibration buffer. 4. Storage Untreated Packing Material: Store sealed at room temperature. Used Packing Material: Thoroughly rinse out salts with pure water. Finally, store in 20% ethanol at 4°C. 5. Precautions a) Before sample application, samples must be membrane-filtered and decolorized. Otherwise, impurities and pigments may adsorb onto the packing material, affecting its performance. All buffers must be filtered through a 0.45 µm filter. 6. Particle Size Specifications Fine Particles: Slow flow rate, optimal separation resolution. Coarse Particles: Fast flow rate, reduced separation resolution. Medium Particles: Moderate flow rate, moderate separation resolution. This type is most commonly selected by customers.  (Please use freshly prepared in vivo formulations for optimal results.) |
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.